Omeprazole Tablets Recalled Due to Improper Storage Conditions
Good Sense and Prilosec OTC omeprazole tablets distributed by Family Dollar Stores have been recalled due to improper storage temperature conditions. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a FDA Class II recall with no reported illnesses or injuries. The hazard is a CGMP deviation from improper storage conditions, representing a manufacturing quality issue rather than active contamination or direct health threat.
Plain-English summary
Good Sense Omeprazole Tablet 14-count (SKU 900055) and Prilosec OTC Tablet 14-count (SKU 914128) have been recalled by Family Dollar Stores, LLC.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The products were held outside appropriate storage temperature conditions, which may affect product stability and quality. The affected products were distributed nationwide within the United States from April 30, 2022 through June 10, 2022.
No illnesses or injuries have been reported in connection with this recall. Consumers who have purchased the recalled products may return them to the place of purchase for a refund or contact Family Dollar Stores, LLC for additional information.
The recalled product
- Product
- GOOD SENSE OMEPRAZOLE TABLET 14CT SKU 900055 PRILOSEC OTC TABLET 14 CT SKU914128 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- improper-storage
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 900055
- 914128
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27